Fluorine in PDB 4r5y: The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor
Enzymatic activity of The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor
All present enzymatic activity of The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor:
2.7.11.1;
Protein crystallography data
The structure of The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor, PDB code: 4r5y
was solved by
Y.Feng,
H.Peng,
Y.Zhang,
Y.Liu,
M.Wei,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
41.18 /
3.50
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
49.395,
101.601,
109.786,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
22.5 /
30.6
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor
(pdb code 4r5y). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor, PDB code: 4r5y:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 4r5y
Go back to
Fluorine Binding Sites List in 4r5y
Fluorine binding site 1 out
of 6 in the The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:49.3
occ:1.00
|
F2
|
A:3K3801
|
0.0
|
49.3
|
1.0
|
C19
|
A:3K3801
|
1.3
|
49.7
|
1.0
|
F1
|
A:3K3801
|
2.1
|
49.1
|
1.0
|
F
|
A:3K3801
|
2.2
|
49.9
|
1.0
|
C18
|
A:3K3801
|
2.3
|
50.2
|
1.0
|
C17
|
A:3K3801
|
2.9
|
50.9
|
1.0
|
CD2
|
A:HIS574
|
3.3
|
48.3
|
1.0
|
C20
|
A:3K3801
|
3.5
|
50.1
|
1.0
|
CD2
|
A:LEU567
|
4.0
|
46.6
|
1.0
|
NE2
|
A:HIS574
|
4.0
|
48.8
|
1.0
|
CG
|
A:HIS574
|
4.1
|
47.8
|
1.0
|
CD1
|
A:LEU567
|
4.2
|
45.7
|
1.0
|
C16
|
A:3K3801
|
4.3
|
51.1
|
1.0
|
CG2
|
A:ILE572
|
4.5
|
45.6
|
1.0
|
CB
|
A:HIS574
|
4.6
|
47.4
|
1.0
|
C21
|
A:3K3801
|
4.6
|
51.1
|
1.0
|
CA
|
A:HIS574
|
4.7
|
47.3
|
1.0
|
CG
|
A:LEU567
|
4.8
|
45.6
|
1.0
|
C15
|
A:3K3801
|
5.0
|
51.1
|
1.0
|
CE1
|
A:HIS574
|
5.0
|
48.6
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 4r5y
Go back to
Fluorine Binding Sites List in 4r5y
Fluorine binding site 2 out
of 6 in the The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:49.9
occ:1.00
|
F
|
A:3K3801
|
0.0
|
49.9
|
1.0
|
C19
|
A:3K3801
|
1.3
|
49.7
|
1.0
|
F1
|
A:3K3801
|
2.1
|
49.1
|
1.0
|
F2
|
A:3K3801
|
2.2
|
49.3
|
1.0
|
C18
|
A:3K3801
|
2.3
|
50.2
|
1.0
|
C17
|
A:3K3801
|
3.1
|
50.9
|
1.0
|
C20
|
A:3K3801
|
3.3
|
50.1
|
1.0
|
CD2
|
A:LEU567
|
3.6
|
46.6
|
1.0
|
O
|
A:VAL504
|
4.0
|
50.4
|
1.0
|
CG2
|
A:THR508
|
4.1
|
48.4
|
1.0
|
CG2
|
A:VAL504
|
4.2
|
50.3
|
1.0
|
CG2
|
A:ILE572
|
4.2
|
45.6
|
1.0
|
C16
|
A:3K3801
|
4.4
|
51.1
|
1.0
|
C21
|
A:3K3801
|
4.5
|
51.1
|
1.0
|
CG2
|
A:ILE513
|
4.6
|
47.4
|
1.0
|
CD1
|
A:ILE572
|
4.7
|
46.1
|
1.0
|
CD2
|
A:LEU505
|
4.7
|
50.6
|
1.0
|
C
|
A:VAL504
|
4.7
|
50.2
|
1.0
|
CB
|
A:VAL504
|
4.9
|
50.0
|
1.0
|
CG
|
A:LEU567
|
4.9
|
45.6
|
1.0
|
C15
|
A:3K3801
|
5.0
|
51.1
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 4r5y
Go back to
Fluorine Binding Sites List in 4r5y
Fluorine binding site 3 out
of 6 in the The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:49.1
occ:1.00
|
F1
|
A:3K3801
|
0.0
|
49.1
|
1.0
|
C19
|
A:3K3801
|
1.3
|
49.7
|
1.0
|
F2
|
A:3K3801
|
2.1
|
49.3
|
1.0
|
F
|
A:3K3801
|
2.1
|
49.9
|
1.0
|
C18
|
A:3K3801
|
2.3
|
50.2
|
1.0
|
C20
|
A:3K3801
|
2.6
|
50.1
|
1.0
|
CG2
|
A:ILE513
|
3.4
|
47.4
|
1.0
|
C17
|
A:3K3801
|
3.6
|
50.9
|
1.0
|
CD2
|
A:LEU567
|
3.7
|
46.6
|
1.0
|
C21
|
A:3K3801
|
4.0
|
51.1
|
1.0
|
O
|
A:ILE592
|
4.1
|
47.9
|
1.0
|
CA
|
A:GLY593
|
4.4
|
49.3
|
1.0
|
CD1
|
A:LEU567
|
4.4
|
45.7
|
1.0
|
CD1
|
A:ILE513
|
4.5
|
46.3
|
1.0
|
CD2
|
A:HIS574
|
4.6
|
48.3
|
1.0
|
C
|
A:ILE592
|
4.6
|
48.1
|
1.0
|
CG
|
A:LEU567
|
4.7
|
45.6
|
1.0
|
C16
|
A:3K3801
|
4.7
|
51.1
|
1.0
|
N
|
A:GLY593
|
4.7
|
48.7
|
1.0
|
CB
|
A:ILE513
|
4.8
|
46.9
|
1.0
|
C15
|
A:3K3801
|
4.9
|
51.1
|
1.0
|
CG2
|
A:THR508
|
4.9
|
48.4
|
1.0
|
CG2
|
A:ILE592
|
4.9
|
47.2
|
1.0
|
N1
|
A:3K3801
|
5.0
|
51.3
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 4r5y
Go back to
Fluorine Binding Sites List in 4r5y
Fluorine binding site 4 out
of 6 in the The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:49.2
occ:1.00
|
F2
|
B:3K3801
|
0.0
|
49.2
|
1.0
|
C19
|
B:3K3801
|
1.3
|
49.9
|
1.0
|
F1
|
B:3K3801
|
2.1
|
50.0
|
1.0
|
F
|
B:3K3801
|
2.2
|
49.9
|
1.0
|
C18
|
B:3K3801
|
2.3
|
50.0
|
1.0
|
C17
|
B:3K3801
|
3.2
|
49.8
|
1.0
|
C20
|
B:3K3801
|
3.2
|
49.8
|
1.0
|
CD1
|
B:LEU567
|
3.4
|
47.6
|
1.0
|
CG
|
B:HIS574
|
3.8
|
48.7
|
1.0
|
CD2
|
B:HIS574
|
3.9
|
48.5
|
1.0
|
CB
|
B:HIS574
|
4.1
|
48.8
|
1.0
|
CD2
|
B:LEU567
|
4.1
|
47.7
|
1.0
|
ND1
|
B:HIS574
|
4.2
|
48.8
|
1.0
|
NE2
|
B:HIS574
|
4.3
|
48.6
|
1.0
|
CG
|
B:LEU567
|
4.4
|
47.3
|
1.0
|
C16
|
B:3K3801
|
4.4
|
49.7
|
1.0
|
C21
|
B:3K3801
|
4.4
|
50.0
|
1.0
|
CG2
|
B:ILE592
|
4.4
|
47.4
|
1.0
|
CE1
|
B:HIS574
|
4.5
|
49.1
|
1.0
|
CA
|
B:GLY593
|
4.5
|
48.7
|
1.0
|
CA
|
B:HIS574
|
4.9
|
48.8
|
1.0
|
C15
|
B:3K3801
|
4.9
|
49.9
|
1.0
|
O
|
B:ILE592
|
4.9
|
47.4
|
1.0
|
N
|
B:GLY593
|
4.9
|
47.8
|
1.0
|
CD1
|
B:ILE513
|
4.9
|
46.6
|
1.0
|
C
|
B:GLY593
|
5.0
|
49.2
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 4r5y
Go back to
Fluorine Binding Sites List in 4r5y
Fluorine binding site 5 out
of 6 in the The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:49.9
occ:1.00
|
F
|
B:3K3801
|
0.0
|
49.9
|
1.0
|
C19
|
B:3K3801
|
1.3
|
49.9
|
1.0
|
F1
|
B:3K3801
|
2.1
|
50.0
|
1.0
|
F2
|
B:3K3801
|
2.2
|
49.2
|
1.0
|
C18
|
B:3K3801
|
2.4
|
50.0
|
1.0
|
C17
|
B:3K3801
|
2.9
|
49.8
|
1.0
|
CG1
|
B:VAL504
|
3.5
|
48.1
|
1.0
|
C20
|
B:3K3801
|
3.5
|
49.8
|
1.0
|
CG2
|
B:ILE572
|
3.7
|
47.3
|
1.0
|
CD2
|
B:LEU567
|
3.9
|
47.7
|
1.0
|
C16
|
B:3K3801
|
4.2
|
49.7
|
1.0
|
CD1
|
B:LEU567
|
4.2
|
47.6
|
1.0
|
CG
|
B:LEU567
|
4.7
|
47.3
|
1.0
|
C21
|
B:3K3801
|
4.7
|
50.0
|
1.0
|
CB
|
B:HIS574
|
4.9
|
48.8
|
1.0
|
CB
|
B:ILE572
|
5.0
|
47.4
|
1.0
|
C15
|
B:3K3801
|
5.0
|
49.9
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 4r5y
Go back to
Fluorine Binding Sites List in 4r5y
Fluorine binding site 6 out
of 6 in the The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of The Complex Structure of Braf V600E Kinase Domain with A Novel Braf Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:50.0
occ:1.00
|
F1
|
B:3K3801
|
0.0
|
50.0
|
1.0
|
C19
|
B:3K3801
|
1.3
|
49.9
|
1.0
|
F2
|
B:3K3801
|
2.1
|
49.2
|
1.0
|
F
|
B:3K3801
|
2.1
|
49.9
|
1.0
|
C18
|
B:3K3801
|
2.3
|
50.0
|
1.0
|
C20
|
B:3K3801
|
2.6
|
49.8
|
1.0
|
CD2
|
B:LEU567
|
3.4
|
47.7
|
1.0
|
CG2
|
B:ILE513
|
3.4
|
46.8
|
1.0
|
C17
|
B:3K3801
|
3.6
|
49.8
|
1.0
|
C21
|
B:3K3801
|
4.0
|
50.0
|
1.0
|
CD1
|
B:LEU567
|
4.1
|
47.6
|
1.0
|
CD1
|
B:ILE513
|
4.2
|
46.6
|
1.0
|
CG2
|
B:THR508
|
4.3
|
48.0
|
1.0
|
CG
|
B:LEU567
|
4.4
|
47.3
|
1.0
|
CB
|
B:ILE513
|
4.7
|
46.4
|
1.0
|
CG1
|
B:ILE513
|
4.7
|
46.2
|
1.0
|
C16
|
B:3K3801
|
4.7
|
49.7
|
1.0
|
O
|
B:ILE592
|
4.7
|
47.4
|
1.0
|
C15
|
B:3K3801
|
4.9
|
49.9
|
1.0
|
CD2
|
B:LEU505
|
5.0
|
49.0
|
1.0
|
|
Reference:
Z.Tang,
X.Yuan,
R.Du,
S.H.Cheung,
G.Zhang,
J.Wei,
Y.Zhao,
Y.Feng,
H.Peng,
Y.Zhang,
Y.Du,
X.Hu,
W.Gong,
Y.Liu,
Y.Gao,
Y.Liu,
R.Hao,
S.Li,
S.Wang,
J.Ji,
L.Zhang,
S.Li,
D.Sutton,
M.Wei,
C.Zhou,
L.Wang,
L.Luo.
Bgb-283, A Novel Raf Kinase and Egfr Inhibitor, Displays Potent Antitumor Activity in Braf-Mutated Colorectal Cancers. Mol.Cancer Ther. V. 14 2187 2015.
ISSN: ISSN 1535-7163
PubMed: 26208524
DOI: 10.1158/1535-7163.MCT-15-0262
Page generated: Thu Aug 1 05:31:55 2024
|